Search - tctmd.com

Displaying 361 - 380 of 471

Sort: Relevancy | Date

Presentation TCT 2013

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Presenter: Andreas R?ck

October 29, 2013

Presentation TCT 2013

Case Presentations: The Issue: Introducing Two Cases of Mitral Regurgitation (One Degenerative MR, One Functional MR) Which Might Invoke Different Approaches

Presenter: Francesco Maisano

October 29, 2013

Presentation TCT 2013

Case Presentation #2: Acute Anterior MI Presenting with Cardiogenic Shock and Complicated by Severe Mitral Regurgitation

Presenter: Anita Asgar

October 29, 2013

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

Presentation TCT 2013

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

Presenter: Blase Carabello

October 28, 2013

Presentation TCT 2013

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Presenter: Alec Vahanian

October 28, 2013

Presentation TCT 2013

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Presenter: Jeffrey Borer

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

Presenter: Dominique Himbert

October 28, 2013

Presentation TCT 2013

MitraClip: Utility in Functional Mitral Regurgitation

Presenter: Laura Mauri

October 28, 2013

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

Are Medical Therapies Beneficial in Functional Mitral Regurgitation? A Critical Appraisal

Presenter: Robert Bonow

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation

Presenter: John Webb

October 27, 2013

Presentation TCT 2013

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

Presenter: Tim Lapp

October 27, 2013

News Daily News

MitraClip Gains FDA Approval for Nonsurgical Patients

October 25, 2013

News Industry News

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

October 25, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

Presentation

Interplay Between Mitral Regurgitation and TAVR with CoreValve

Presenter: F. Bedogni

October 07, 2013

News Daily News

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

L.A. McKeown

September 20, 2013

Advertisement

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Case Presentations: The Issue: Introducing Two Cases of Mitral Regurgitation (One Degenerative MR, One Functional MR) Which Might Invoke Different Approaches

Case Presentation #2: Acute Anterior MI Presenting with Cardiogenic Shock and Complicated by Severe Mitral Regurgitation

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

MitraClip: Utility in Functional Mitral Regurgitation

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Are Medical Therapies Beneficial in Functional Mitral Regurgitation? A Critical Appraisal

Mitral Regurgitation

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

MitraClip Gains FDA Approval for Nonsurgical Patients

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

Interplay Between Mitral Regurgitation and TAVR with CoreValve

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content